- Asked by: Christine Grahame, MSP for South of Scotland, Scottish National Party
-
Date lodged: Wednesday, 23 June 2004
-
Current Status:
Answered by Tavish Scott on 7 July 2004
To ask the Scottish Executive how much capital debt is owed by each local authority, expressed as also per capita.
Answer
The information requested is given in table 10 of the Scottish Local Government Financial Statistics 2002-03 published by The Scottish Executive in 2004, a copy of which is available in the Parliament’s Reference Centre (Bib. number 32947).
- Asked by: Christine Grahame, MSP for South of Scotland, Scottish National Party
-
Date lodged: Wednesday, 23 June 2004
-
Current Status:
Answered by Cathy Jamieson on 6 July 2004
To ask the Scottish Executive what percentage of all victims of sexual assault in each of the last five years was children.
Answer
The statistics available centrally on crimes of sexual assault recorded by the police do not enable the age of the victim to be identified.
- Asked by: Christine Grahame, MSP for South of Scotland, Scottish National Party
-
Date lodged: Wednesday, 23 June 2004
-
Current Status:
Answered by Cathy Jamieson on 1 July 2004
To ask the Scottish Executive, further to the answer to question S2W-8837 by Cathy Jamieson on 18 June 2004, how many people were convicted of drink-driving in (a) 1999-2000, (b) 2000-01 and (c) 2001-02.
Answer
The information requested, which is available for calendar years, is given in table 19 of statistical bulletin Criminal Proceedings in Scottish Courts, 2002 published by the Scottish Executive in February 2004. A copy of the bulletin is available in the Parliament’s Reference Centre (Bib. number 31304).
- Asked by: Christine Grahame, MSP for South of Scotland, Scottish National Party
-
Date lodged: Friday, 18 June 2004
-
Current Status:
Answered by Malcolm Chisholm on 1 July 2004
To ask the Scottish Executive, with reference to paragraph 5.1 of Final Consensus Statement of the Royal College of Physicians' Consensus Conference on Hepatitis C, what measures it is taking, and are planned, to reduce non-attendance at hepatitis C virus services (HCV), enhance referral to HCV services, improve data collection and service audit within the framework of managed clinical networks.
Answer
These are issues, which are being considered in the context of the action plan, to which the answer given to question S2W-9189 on 2 July 2004 refers. All answers to written parliamentary questions are available on the Parliament’s website, the search facility for which can be found at
http://www.scottish.parliament.uk/webapp/search_wa.
- Asked by: Christine Grahame, MSP for South of Scotland, Scottish National Party
-
Date lodged: Friday, 18 June 2004
-
Current Status:
Answered by Malcolm Chisholm on 1 July 2004
To ask the Scottish Executive, with reference to paragraph 3.3 of Final Consensus Statement of the Royal College of Physicians' Consensus Conference on Hepatitis C, what measures are being taken to encourage patient involvement, given that half of those referred do not attend clinics.
Answer
This is an issue which is being considered in the context of the action plan to which the answer given to question S2W-9189 on 1 July 2004 refers. All answers to written parliamentary questions are available on the Parliament’s website, the search facility for which can be found at
http://www.scottish.parliament.uk/webapp/search_wa.
- Asked by: Christine Grahame, MSP for South of Scotland, Scottish National Party
-
Date lodged: Friday, 18 June 2004
-
Current Status:
Answered by Malcolm Chisholm on 1 July 2004
To ask the Scottish Executive, with reference to paragraph 4.4 of Final Consensus Statement of the Royal College of Physicians' Consensus Conference on Hepatitis C, what its response is in respect of the call for new drug therapies.
Answer
The regulation and safety of medicines is reserved and is the responsibility of the Medicines and Healthcare products Regulatory Agency (MRHA), or, for certain types of drugs, the European Medicines Agency (EMEA).
The MRHA has advised that any new drug applications, including those for Hepatitis C must achieve the required standards of safety, quality and efficacy before being granted a licence. The Scottish Executive would welcome any new drug therapies, which satisfied these criteria.
- Asked by: Christine Grahame, MSP for South of Scotland, Scottish National Party
-
Date lodged: Friday, 18 June 2004
-
Current Status:
Answered by Malcolm Chisholm on 1 July 2004
To ask the Scottish Executive, with reference to the key messages of Final Consensus Statement of the Royal College of Physicians' Consensus Conference on Hepatitis C, what resources have been allocated to improving the (a) prevention of hepatitis C and (b) delivery of care to patients with hepatitis C in (i) 1999-2000, (ii) 2000-01, (iii) 2001-02, (iv) 2002-03, (v) 2003-04 and (vi) 2004-05 to date in (1) Scotland as a whole and (2) each NHS board area.
Answer
As recommended in the
Report of the HIV Health Promotion Strategy Review Group, published in January 2001, the Executive extended the earmarked HIV prevention funding provided annually to NHS Boards to include other bloodborne viruses, particularly Hepatitis C. Funding for this purpose was accordingly increased from £6.1 million in 1999-2000 to £8.1 million in 2001-02. Allocations to individual boards are shown in the table below.
| NHS Board | 2001-02 | 2002-03 | 2003-04 | 2004-05 |
| Argyll and Clyde | £415,922 | £415,922 | £415,922 | £415,922 |
| Ayrshire and Arran | £370,000 | £350,000 | £350,000 | £350,000 |
| Borders | £116,498 | £115,498 | £115,498 | £115,498 |
| Dumfries and Galloway | £116,804 | £115,804 | £115,804 | £115,804 |
| Fife | £408,062 | £408,061 | £408,061 | £408,061 |
| Forth Valley | £276,705 | £276,705 | £276,705 | £276,705 |
| Grampian | £690,825 | £690,825 | £690,825 | £690,825 |
| Greater Glasgow | £1,555,208 | £1,560,208 | £1,560,208 | £1,560,208 |
| Highland | £200,197 | £200,197 | £200,197 | £200,197 |
| Lanarkshire | £441,775 | £441,775 | £441,775 | £441,775 |
| Lothian | £2,505,627 | £2,524,627 | £2,524,627 | £2,524,627 |
| Orkney | £39,000 | £36,000 | £36,000 | £36,000 |
| Shetland | £56,000 | £55,000 | £55,000 | £55,000 |
| Tayside | £854,377 | £861,377 | £861,377 | £861,377 |
| Western Isles | £48,000 | £47,000 | £47,000 | £47,000 |
| State Hospital | £24,000 | £20,000 | £20,000 | £20,000 |
| Totals | £8,119,000 | £8,119,000 | £8,119,000 | £8,119,000 |
In addition, the Executive has provided an additional £34 million to NHS boards and local authorities over the three years 2001-02 to 2003-04 to support treatment and rehabilitation programmes for drug misusers, including those who inject drugs. There is evidence that treatment reduces the use of illegal drugs and levels of injecting. Sharing of contaminated injecting equipment is one of the main routes through which Hepatitis C can be transmitted.
As well as these specific allocations, NHS boards are given a unified budget to meet the healthcare needs of their resident populations. It is for each board to decide how best to utilise this funding, based on their assessment of local needs, including Hepatitis C
- Asked by: Christine Grahame, MSP for South of Scotland, Scottish National Party
-
Date lodged: Friday, 18 June 2004
-
Current Status:
Answered by Malcolm Chisholm on 1 July 2004
To ask the Scottish Executive, with reference to paragraph 5.2 of Final Consensus Statement of the Royal College of Physicians' Consensus Conference on Hepatitis C, what economic analysis it has undertaken in order to inform resource allocation decisions in relation to the treatment and prevention of hepatitis C over the next 10 years.
Answer
The Scottish Centre for Infection and Environmental Health (SCIEH) has been commissioned to carry out work to provide robust estimates of the total number of persons living with Hepatitis C – both diagnosed and undiagnosed – in Scotland. This includes estimates of the distribution of cases by region and disease stage. The SCIEH is also undertaking work to estimate the future burden, including cost, of HCV disease over the next two decades. Preliminary output from this work should be available shortly and will inform the development of prevention initiatives, and the assessment of care and treatment needs.
- Asked by: Christine Grahame, MSP for South of Scotland, Scottish National Party
-
Date lodged: Friday, 18 June 2004
-
Current Status:
Answered by Malcolm Chisholm on 1 July 2004
To ask the Scottish Executive, with reference to paragraph 3.6 of Final Consensus Statement of the Royal College of Physicians' Consensus Conference on Hepatitis C, how many outreach clinics there are for patients with hepatitis C, broken down by NHS board area.
Answer
This information is not available centrally.
- Asked by: Christine Grahame, MSP for South of Scotland, Scottish National Party
-
Date lodged: Friday, 18 June 2004
-
Current Status:
Answered by Malcolm Chisholm on 1 July 2004
To ask the Scottish Executive how many hepatitis C patients there have been in (a) Scotland as a whole and (b) each NHS board area in (i) 1999-2000, (ii) 2000-01, (iii) 2001-02, (iv) 2002-03, (v) 2003-04 and (vi) 2004-05 to date.
Answer
The latest available figures are for the year ended 31 December 2003, and are set out in the table below.
Persons in Scotland Reported to be Hepatitis C Antibody-Positive; Number and Rate/100000 Population* by NHS Board and Year of Earliest Positive Specimen to 31 December 2003
| | 1999 | 2000 | 2001 | 2002 | 2003 |
| Argyll and Clyde | Number | 160 | 149 | 128 | 163 | 127 |
| Rate/100,000 | 37.6 | 35.2 | 30.4 | 38.9 | 30.5 |
| Ayrshire and Arran | Number | 119 | 145 | 103 | 145 | 149 |
| Rate/100,000 | 31.8 | 38.8 | 28.0 | 39.5 | 40.6 |
| Borders | Number | 3 | 8 | 5 | 11 | 13 |
| Rate/100,000 | 2.8 | 7.5 | 4.7 | 10.2 | 12.0 |
| Dumfries and Galloway | Number | 34 | 57 | 88 | 54 | 46 |
| Rate/100,000 | 23.2 | 39.1 | 59.5 | 36.7 | 31.2 |
| Fife | Number | 62 | 66 | 63 | 37 | 30 |
| Rate/100,000 | 17.8 | 18.8 | 18.0 | 10.6 | 8.5 |
| Forth Valley | Number | 86 | 98 | 81 | 91 | 67 |
| Rate/100,000 | 31.0 | 35.3 | 29.0 | 32.6 | 24.0 |
| Grampian | Number | 278 | 381 | 343 | 341 | 320 |
| Rate/100,000 | 52.9 | 72.8 | 65.2 | 65.2 | 61.1 |
| Greater Glasgow | Number | 753 | 701 | 644 | 845 | 576 |
| Rate/100,000 | 83.1 | 77.5 | 74.2 | 97.6 | 66.5 |
| Highland | Number | 41 | 34 | 47 | 43 | 44 |
| Rate/100,000 | 19.7 | 16.3 | 22.5 | 20.7 | 21.0 |
| Lanarkshire | Number | 110 | 131 | 95 | 180 | 124 |
| Rate/100,000 | 19.6 | 23.3 | 17.2 | 32.6 | 22.4 |
| Lothian | Number | 186 | 266 | 209 | 181 | 103 |
| Rate/100,000 | 23.9 | 33.9 | 26.8 | 23.2 | 13.2 |
| Orkney | Number | 0 | 0 | 1 | 2 | 0 |
| Rate/100,000 | 0.0 | 0.0 | 5.2 | 10.4 | 0.0 |
| Shetland | Number | 1 | 5 | 2 | 3 | 3 |
| Rate/100,000 | 4.4 | 22.3 | 9.1 | 13.7 | 13.7 |
| Tayside | Number | 128 | 134 | 95 | 229 | 177 |
| Rate/100,000 | 33.0 | 34.8 | 24.4 | 59.1 | 45.8 |
| Western Isles | Number | 0 | 0 | 0 | 0 | 0 |
| Rate/100,000 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Scotland | Number | 1961 | 2175 | 1904 | 2325 | 1779 |
| Rate/100,000 | 38.3 | 42.5 | 37.6 | 46.0 | 35.2 |
Source: The Scottish Centre for Infection and Environmental Health, Glasgow, Scotland – 24 June 2004.
Note:
*Based on population estimates at 30 June of given year.
